Science & innovation

Each new medicine begins with an idea

 

Explore our science & innovation

Our therapy areas

Our expertise in treating serious chronic diseases

 

Explore our therapy areas

Partner with us

Our philosophy of scientific collaboration

 

Partner with us

Pipeline

Our scientists are constantly breaking new ground

 

Explore our pipeline


Our scientific approach

As a global healthcare provider, Novo Nordisk's key contribution is to discover and develop innovative medicines. Chief Science Officer Mads Krogsgaard Thomsen explains how we "innovate to improve the lives of people living with diabetes and other serious chronic diseases worldwide".

 

See how we work

Our cutting edge science published

For decades, Novo Nordisk researchers have worked on oral delivery of peptides, and finally we have the evidence to support the specific mechanism for absorption of the peptide hormone GLP-1 in a co-formulation with SNAC (red staining on picture)  in the stomach. The research findings were recently published in Science Translational Medicine.

Read the publication


Our therapy areas


Partnering opportunities

We are looking to work with external partners that have complementary expertise to our own, both across our therapy areas and within each step of the pharmaceutical value chain.

 

Explore partnering opportunities


A global approach to R&D

Novo Nordisk's research and development facilities in Denmark, USA, UK, India and China form a global network that covers the entire pharmaceutical value chain across our therapy areas.

 

Visit our R&D facilities


Explore R&D

Publications

We proudly and regularly publish our scientists’ new findings.

 

Explore our publications

Contact us

We can turn your ideas into new medicines.

 

Contact us

Careers in R&D

We are looking for scientific talent to join us.

 

View R&D jobs

Where to meet us

We attend partnering events and scientific conferences all over the world.
 

View our events calendar